Wireless signals could diagnose brain swelling; Regulatory risk could dampen med tech investment;

@FierceMedDev: New special report: After tough times, hip implant revenue projected to grow again. Feature | Follow @FierceMedDev

@MarkHFierce: Roche may be selling its glucose meter business, Reuters reports--blame competition and worsening reimbursement. Story | Follow @MarkHFierce

 @DamianFierce: In case you missed it: Hospira endured another FDA warning letter, this time over the pumps it wants to keep. Article | Follow @DamianFierce

> Saudi surgeons say they've successfully implanted electrodes for a cochlear implant into the brainstem of a 3-year-old child. Story

> Illumina ($ILMN) has launched BaseSpace, a cloud-based computing and storage platform for genomic data. News

> Despite accounting for only 0.6% of the global medical device market, Israel is No. 1 in device patents per capita, a sign that the country's local industry is on the rise. Article

> A team at the University of California in Berkeley has come up with a system of wireless signals to provide, quick, efficient and accurate non-invasive diagnoses of brain swelling or bleeding. Item

> An EU court has clarified the meaning of the term "medical device" as part of an ongoing legal case. Item

> Regulatory risk is preventing more med tech investment, an industry panel recently argued in Sacramento. Story

> Europe's dive into recession could cause more struggles for devicemakers down the line. Story

Biotech News

@FierceBiotech: In case you missed it last night: Scientists use cloning method to create embryonic stem cells. Article | Follow @FierceBiotech

@JohnCFierce: Roche's next-gen Rituxan candidate impresses in first look at PhIII data. Report | Follow @JohnCFierce

@RyanMFierce: @SanofiUS hunts for clinical trial recruits in growing social network. Article | Follow @RyanMFierce

> AstraZeneca revs up PhIII cancer plans as rivals steal ASCO spotlight. News

> Gilead speeds ahead on idelalisib with promising leukemia data. Story

> Amgen, Novartis aim to fuel biotech startups in alliance with Atlas Venture. Article

Pharma News

@FiercePharma: AstraZeneca advances three cancer drugs into late-stage trials. Story | Follow @FiercePharma

@EricPFierce:  Pfizer to give privileges to small group of contract manufacturers as it makes network more efficient. Article | Follow @EricPFierce

> WSJ: Novartis sniffs around $16B offer for Actavis. Article

> Novartis properly warned of Zometa's risks, jury decides. Story

> Colitis nod puts J&J's Simponi one step closer to blockbuster. More

Pharma Manufacturing News

> CEO of J&J OTC unit in Korea faces criminal action over plant foul-up. News

> Recalls jump 32% in first quarter. Article

> Pfizer to close Ireland plant by next year. Story

> Pfizer to pick some contract manufacturers for new elevated role. More

Vaccines News

> Taliban drops campaign against polio vaccine. News

> Human-to-human coronavirus spread looks likely. Item

> Cash injection raises hopes of diabetes vaccine. More

> Media reports used to track global vaccine backlash. Article

> Indian rotavirus vax set to undercut GSK and Merck. Story

Suggested Articles

In an SEC filing, Baxter International disclosed that it may have overstated its income over multiple years, inflating it by about $276 million.

The FDA has given Grail a green light to conduct the interventional study, and it has begun enrolling participants through the company’s R&D partners.

Coronavirus may not require a front-line battle yet in certain places, but it’s still taxing public health officials preparing for a potential crisis.